cltc certification, |
||||||
|
News for 22-Apr-25 Source: MedicineNet Asthma General Source: MedicineNet Diabetes General Source: MedicineNet Diabetes General Source: MedicineNet Diabetes General Source: MedicineNet Asthma General Source: MedicineNet Asthma General Source: MedicineNet Diabetes General Source: MedicineNet Diabetes General Source: MedicineNet Asthma General Source: MedicineNet Diabetes General
|
The Best cltc certification, websiteAll the cltc certification, information you need to know about is right
here. Presented and researched by http://www.medical-mailings.com. We've searched
the information super highway far and wide to provide you with the
best cltc certification, site on the internet today. The links below will
assist you in your efforts to find the information that you are looking
for about
cltc certification,
After you have carefully reviewed the cltc certification, results from your search you are then ready to bookmark the best of them. Again just select the menu item Add to Favorites but this time click on Create In and then select the cltc certification, folder. Place all of your cltc certification, website bookmarks in this folder for future reference. When you need to revisit the cltc certification, sites you can easily do so my selecting Favorites from the menu bar and then selecting the cltc certification, folder and the relevant link. It's as simple as ABC. cltc certification,
Welcome to the Internet. Like it or lump it you'll find much more than you need. That's where we come in and provide assistance. We've done the research for you and found the very best links on cltc certification,. Our primary role in this process is to search for information on cltc certification,, evaluate it and then determine whether it is likely to meet your needs. We won't be bold enough to call ourselves cltc certification, librarians but in one sense that it what we are doing. cltc certification, information exists in a large variety of formats and genres (facts, opinions, cltc certification, stories, interpretations and so on). This information has been created to inform, persuade and educate you on all that you ever need to know about cltc certification,. The quality ranges from poor to brilliant with lots of shades in between. Treating Chronic Mutational Hepatitis B with Chinese Medicine Vitalliver (Vigconic Suppositories) by: ZHANG GUAN HUA, LIANG CHAO, ZHENG WAN PIN
Treating chronic mutational hepatitis B with Chinese medicine Vitalliver (Vigconic suppositories)
Research Method: Quantitative determination by contrasting HBV-DNA of cases before and after the treatment. Number of cases: 25 (n) Case Selection: Between the age of 16 and 65, in accordance with the diagnosis standards pf chronic Hepatitis B, with negative e antigen and positive e antibody, HBV-DNA > 1×104 cp/mL. Detection Method: All the blood samples are detected by Sichuan Clinical Detection Center; PCR-ELISA quantitative determination is used within detection range of 1×104 - 1×107-8, HBV-DNA, unit of measurement is cp/mL. Direction Plan: one suppository provided by Vigconic (International) Ltd. Bid. The course of treatment is six months, the tracing observation after withdrawal lasts six months. Observation index:
Criterion of Therapeutic Effect:
HBV-DNA volume 1×104 cp/mL: 2/25 (8%) Among the results of lasting response, 16 blood serum samples are detected through fluorimetric quantitative determination PCR by the instruments of PE.USD, H-7700 in the second attached hospital of Guangzhou Medical College. The result is in accordance with that in Sichuan Clinical Testing Center. (8 cases among it < 1×102 cp/mL). The testing range of this testing method is 1×102 - 1×107-8 cp/mL. Conclusion The reason for the repeatedly abnormal liver function of Chronic Hepatitis B (CHB) patients lies in the repeatedly duplication of HBV after infection, which leads to fibrosis of liver, then cirrhosis and liver cancer. It is commonly accepted that if CHB shows the transformation of HBeAg/Anti-HBe, HBV-DNA becoming negative, liver function returning to normal state, the disease is relieved. However, parts of patients with the transformation of HBeAg/Anti-HBe still remain positive in HBV-DNA and the pathological change in the liver continues. Because HBV-DNA occurs promoter mutation in the anterior C section (1896 necleoside G-A variation) or in the C section (1762 nucleoside T variation, 1764 G-A variation), HBeAg cannot come into being. Therefore, the HBeAg in the patient's blood cannot be detected, while the virus can keep on duplicating and fixing itself. Through sequential assay of nucleic acid, it proves that promoter mutation appears in 30%-60% of HBeAg negative Chronic Hepatitis B (CHB) in the anterior C section or in the C section. In some provinces and cities of the People of China, the percentage of promoter mutation appears in HBeAg negative Chronic Hepatitis B (CHB) in the anterior C section or in the C section is from 17.6% to 78.9%. Eight out of the 25 cases of our observation go through the sequential assay of nucleic acid carried out by the Department of Microbiology of the University of Hong Kong. It all proves to have HBV-DNA mutation. The chronic mutational Hepatitis B is infectious and apt to cause cirrhosis and liver cancer since the present medicines of antivirus and immuno-modulator do not produce the expected therapeutic effects. Vitalliver suppository is made up from a formula of Chinese herbs, including Ginseng, Deer Horn, Cordyceps, Radix Astragali, Frudctus Cnidii, Semen Cuscutae, etc. The formula is mainly for strengthening the body resistant and primarily for reinforcing Kidney Qi, which produces good therapeutic effects in treating chronic mutational Hepatitis B. The mechanism is probably that through the regulating of immune system, the duplication of virus is inhibited and meanwhile the liver is protected, so it can produce a lasting therapeutic effect. No adverse reaction and severe accident happens during clinical observation, so it is safe for using. Vitalliver is bringing hopes to the treatment of chronic mutational Hepatitis B. * The second stage of clinical trial would be carrying out by the Microbiology Department of the University of Hong Kong and Chengdu University of Traditional Chinese Medicine. For more information, please visit: http://www.vigconic.com
|
|||||
|
http://www.gomailings.com/ |
||||||
| Drugestore On-the-Net fantasy-sports-directory Medical Meetings |